drug treatment Search Results


95
Chem Impex International sodium fluoride
Sodium Fluoride, supplied by Chem Impex International, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/drug+treatment/Sodium+fluoride/bio_rxiv__2024__06__05__597552-145-64-66
Average 95 stars, based on 1 article reviews
sodium fluoride - by Bioz Stars, 2026-10
95/100 stars
  Buy from Supplier

95
Chem Impex International chemical compound
Chemical Compound, supplied by Chem Impex International, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/drug+treatment/Hydrogen+Peroxide%2C+35%25%2C+Food+grade/10__7554_slash_elife__45572-310-102-115
Average 95 stars, based on 1 article reviews
chemical compound - by Bioz Stars, 2026-10
95/100 stars
  Buy from Supplier

90
Adis International Limited avery's drug treatment
Avery's Drug Treatment, supplied by Adis International Limited, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/drug+treatment/avery+s+drug+treatment/us09125880-522-90-95
Average 90 stars, based on 1 article reviews
avery's drug treatment - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier

90
AstraZeneca ltd estimating adverse drug event costs associated with life-prolonging treatments for metastatic castrationresistant prostate cancer
Estimating Adverse Drug Event Costs Associated With Life Prolonging Treatments For Metastatic Castrationresistant Prostate Cancer, supplied by AstraZeneca ltd, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/drug+treatment/estimating+adverse+drug+event+costs+associated+with+life+prolonging+treatments+for+metastatic+castrationresistant+prostate+cancer/pm32293214-610-1-1
Average 90 stars, based on 1 article reviews
estimating adverse drug event costs associated with life-prolonging treatments for metastatic castrationresistant prostate cancer - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier

90
Molecular NeuroImaging antipsychotic drug treatment
Antipsychotic Drug Treatment, supplied by Molecular NeuroImaging, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/drug+treatment/antipsychotic+drug+treatment/pm31444565-14-34-17
Average 90 stars, based on 1 article reviews
antipsychotic drug treatment - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier

90
Wieser GmbH antiepileptic drug treatment
Antiepileptic Drug Treatment, supplied by Wieser GmbH, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/drug+treatment/antiepileptic+drug+treatment/pmc06591702-6610-14-12
Average 90 stars, based on 1 article reviews
antiepileptic drug treatment - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier

90
NanoMed Pharmaceuticals ai powered identification of drug targets and pathways for diagnosis and treatment planning
Ai Powered Identification Of Drug Targets And Pathways For Diagnosis And Treatment Planning, supplied by NanoMed Pharmaceuticals, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/drug+treatment/ai+powered+identification+of+drug+targets+and+pathways+for+diagnosis+and+treatment+planning/10__23880_slash_nnoa___16000232-6-11-15
Average 90 stars, based on 1 article reviews
ai powered identification of drug targets and pathways for diagnosis and treatment planning - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier

90
Otonomy Inc slow-release drug treatments for the ear
Slow Release Drug Treatments For The Ear, supplied by Otonomy Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/drug+treatment/slow+release+drug+treatments+for+the+ear/pmc11727143-211-13-9
Average 90 stars, based on 1 article reviews
slow-release drug treatments for the ear - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier

90
Wakunaga Of America Co Ltd drug treatment age (kyolictm)
Drug Treatment Age (Kyolictm), supplied by Wakunaga Of America Co Ltd, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/drug+treatment/drug+treatment+age++kyolictm+/pmc03391571-78-0-7
Average 90 stars, based on 1 article reviews
drug treatment age (kyolictm) - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier

90
LC Laboratories drug treatment crizotinib
Pharmacological inhibition of ROS1 or MEK1/2 in prepubescent mice prevents IS epithelia differentiation. A, Western blot analysis of lysates from caput epididymides from ROS1 wild-type mice treated with either <t>crizotinib</t> or PD325901 for 0, 5, and 12 days against the indicated proteins. B, Photomicrographs of paraffin-embedded sections from caput epididymides of (A) stained with H&E or for expression of phospho-ERK1/2 by IHC. Scale bar, 250 μm.
Drug Treatment Crizotinib, supplied by LC Laboratories, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/drug+treatment/drug+treatment+crizotinib/pmc04138574-57-0-5
Average 90 stars, based on 1 article reviews
drug treatment crizotinib - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier

90
SipNose LTD drug-device combination treatment
Pharmacological inhibition of ROS1 or MEK1/2 in prepubescent mice prevents IS epithelia differentiation. A, Western blot analysis of lysates from caput epididymides from ROS1 wild-type mice treated with either <t>crizotinib</t> or PD325901 for 0, 5, and 12 days against the indicated proteins. B, Photomicrographs of paraffin-embedded sections from caput epididymides of (A) stained with H&E or for expression of phospho-ERK1/2 by IHC. Scale bar, 250 μm.
Drug Device Combination Treatment, supplied by SipNose LTD, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/drug+treatment/drug+device+combination+treatment/pmc10294342-81-5-11
Average 90 stars, based on 1 article reviews
drug-device combination treatment - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier

90
Zhongrong International Trust Co Ltd drug-coated balloon for endovascular treatment of symptomatic intracranial stenotic disease
Pharmacological inhibition of ROS1 or MEK1/2 in prepubescent mice prevents IS epithelia differentiation. A, Western blot analysis of lysates from caput epididymides from ROS1 wild-type mice treated with either <t>crizotinib</t> or PD325901 for 0, 5, and 12 days against the indicated proteins. B, Photomicrographs of paraffin-embedded sections from caput epididymides of (A) stained with H&E or for expression of phospho-ERK1/2 by IHC. Scale bar, 250 μm.
Drug Coated Balloon For Endovascular Treatment Of Symptomatic Intracranial Stenotic Disease, supplied by Zhongrong International Trust Co Ltd, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/drug+treatment/drug+coated+balloon+for+endovascular+treatment+of+symptomatic+intracranial+stenotic+disease/pmc11157555-835-3-24
Average 90 stars, based on 1 article reviews
drug-coated balloon for endovascular treatment of symptomatic intracranial stenotic disease - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier

Image Search Results


Pharmacological inhibition of ROS1 or MEK1/2 in prepubescent mice prevents IS epithelia differentiation. A, Western blot analysis of lysates from caput epididymides from ROS1 wild-type mice treated with either crizotinib or PD325901 for 0, 5, and 12 days against the indicated proteins. B, Photomicrographs of paraffin-embedded sections from caput epididymides of (A) stained with H&E or for expression of phospho-ERK1/2 by IHC. Scale bar, 250 μm.

Journal: Endocrinology

Article Title: ROS1 Signaling Regulates Epithelial Differentiation in the Epididymis

doi: 10.1210/en.2014-1341

Figure Lengend Snippet: Pharmacological inhibition of ROS1 or MEK1/2 in prepubescent mice prevents IS epithelia differentiation. A, Western blot analysis of lysates from caput epididymides from ROS1 wild-type mice treated with either crizotinib or PD325901 for 0, 5, and 12 days against the indicated proteins. B, Photomicrographs of paraffin-embedded sections from caput epididymides of (A) stained with H&E or for expression of phospho-ERK1/2 by IHC. Scale bar, 250 μm.

Article Snippet: Drug treatment Crizotinib and PD325901 (LC Labs) were reconstituted in DMSO and diluted in Ora-Plus (Paddock) or PBS and administered by oral gavage or ip injection.

Techniques: Inhibition, Western Blot, Staining, Expressing

Peripubertal inhibition of ROS1 kinase activity has no long-term effect on architecture of IS epithelium and fertility. A, Western blot analysis of caput (including IS) from males that were treated with crizotinib between P17 to P28 and aged to P70 for the levels of phospho-ROS1. P21 untreated caput epididymides were used as a positive control. B, The heights of IS epithelium were measured in 2 control and 2 crizotinib-treated (from P17 to P28) in juvenile males immediately posttreatment (P28) and 42 days after cessation of treatment (P70 adult). *, P < .05. C, Peripubertal crizotinib-treated and control mice (N = 5 each) as in (B) were aged to adulthood (10-weeks-old) and mated with 6-week-old females. Copulatory vaginal plugs and pregnancies were recorded and percent fertility calculated as the number of pregnancy/plugs.

Journal: Endocrinology

Article Title: ROS1 Signaling Regulates Epithelial Differentiation in the Epididymis

doi: 10.1210/en.2014-1341

Figure Lengend Snippet: Peripubertal inhibition of ROS1 kinase activity has no long-term effect on architecture of IS epithelium and fertility. A, Western blot analysis of caput (including IS) from males that were treated with crizotinib between P17 to P28 and aged to P70 for the levels of phospho-ROS1. P21 untreated caput epididymides were used as a positive control. B, The heights of IS epithelium were measured in 2 control and 2 crizotinib-treated (from P17 to P28) in juvenile males immediately posttreatment (P28) and 42 days after cessation of treatment (P70 adult). *, P < .05. C, Peripubertal crizotinib-treated and control mice (N = 5 each) as in (B) were aged to adulthood (10-weeks-old) and mated with 6-week-old females. Copulatory vaginal plugs and pregnancies were recorded and percent fertility calculated as the number of pregnancy/plugs.

Article Snippet: Drug treatment Crizotinib and PD325901 (LC Labs) were reconstituted in DMSO and diluted in Ora-Plus (Paddock) or PBS and administered by oral gavage or ip injection.

Techniques: Inhibition, Activity Assay, Western Blot, Positive Control, Control

Inhibition of ROS1 and MEK1/2 kinase activity in adults. A, Western blot analysis of lysates from caput epididymides (including IS) from ROS1 wild-type mice treated with either crizotinib or PD325901 for 0, 7, and 14 days against the indicated proteins. B, Photomicrographs of paraffin-embedded sections from proximal epididymides treated as per (A) and stained with H&E or phospho-ERK1/2 by IHC. Scale bar, 250 μm. C, Western blot analysis of lysates from proximal caput epididymides (including IS) from ROS1 wild-type mice treated with crizotinib for 12 days. D, Crizotinib-treated and control mice were mated with 6-week-old females and copulatory vaginal plugs and pregnancies were recorded, and percent fertility calculated from the number of pregnancy/plugs.

Journal: Endocrinology

Article Title: ROS1 Signaling Regulates Epithelial Differentiation in the Epididymis

doi: 10.1210/en.2014-1341

Figure Lengend Snippet: Inhibition of ROS1 and MEK1/2 kinase activity in adults. A, Western blot analysis of lysates from caput epididymides (including IS) from ROS1 wild-type mice treated with either crizotinib or PD325901 for 0, 7, and 14 days against the indicated proteins. B, Photomicrographs of paraffin-embedded sections from proximal epididymides treated as per (A) and stained with H&E or phospho-ERK1/2 by IHC. Scale bar, 250 μm. C, Western blot analysis of lysates from proximal caput epididymides (including IS) from ROS1 wild-type mice treated with crizotinib for 12 days. D, Crizotinib-treated and control mice were mated with 6-week-old females and copulatory vaginal plugs and pregnancies were recorded, and percent fertility calculated from the number of pregnancy/plugs.

Article Snippet: Drug treatment Crizotinib and PD325901 (LC Labs) were reconstituted in DMSO and diluted in Ora-Plus (Paddock) or PBS and administered by oral gavage or ip injection.

Techniques: Inhibition, Activity Assay, Western Blot, Staining, Control